Parotid gland sparing IMRT for head and neck cancer improves xerostomia related quality of life

被引:0
作者
CM van Rij
WD Oughlane-Heemsbergen
AH Ackerstaff
EA Lamers
AJM Balm
CRN Rasch
机构
[1] Academic Medical Center,Department of Radiotherapy
[2] Amsterdam,Department of Radiation Oncology
[3] The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital,Department of Head and Neck Oncology and Surgery
[4] The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital,Department of Radiation Oncology
[5] The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital,Department of ORL Academic Medical Center Amsterdam the Netherlands Department of Head and Neck Oncology and Surgery
[6] The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital,undefined
来源
Radiation Oncology | / 3卷
关键词
Oral Cavity; Parotid Gland; Submandibular Gland; Artificial Saliva; Laryngeal Cancer Patient;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 134 条
[1]  
Harrison LB(1997)Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue Head Neck 19 169-175
[2]  
Zelefsky MJ(2003)How should we measure and report radiotherapy-induced xerostomia? Semin Radiat Oncol 13 226-234
[3]  
Pfister DG(2004)Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity-modulated radiotherapy (IMRT) for head-and-neck cancer Int J Radiat Oncol Biol Phys 58 663-673
[4]  
Carper E(2003)Influence of parotid-sparing radiotherapy on xerostomia in head and neck cancer patients Cancer Detect Prev 27 305-310
[5]  
Raben A(2001)A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results Int J Radiat Oncol Biol Phys 49 907-916
[6]  
Kraus DH(2004)Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy Int J Radiat Oncol Biol Phys 58 175-184
[7]  
Strong EW(2005)A comparison of mean parotid gland dose with measures of parotid gland function after radiotherapy for head-and-neck cancer: Implications for future trials Int J Radiat Oncol Biol Phys 63 1006-1009
[8]  
Rao A(2005)Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report Int J Radiat Oncol Biol Phys 63 725-731
[9]  
Thaler H(1998)Structured assessment of the consequences of composite resection Clin Otolaryngol Allied Sci 23 339-344
[10]  
Polyak T(2001)Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer Int J Radiat Oncol Biol Phys 50 695-704